Cigarette smoking and gemcitabine-induced neutropenia in advanced solid tumors

Oncology (Switzerland)

Volumn 85, Issue 4, 2013, Pages 216-222

  O'Malley, Meaghan ^a   Healy, Patrick ^b   Daignault, Stephanie ^b   Ramnath, Nithya ^a,c  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

Chemotherapy; Neutropenia; Pharmacodynamics; Smoking

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CAPECITABINE; ERLOTINIB; FLUOROURACIL; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; PLATINUM; SORAFENIB; TAXANE DERIVATIVE;

ADULT; ARTICLE; BREAST CANCER; CANCER OF UNKNOWN PRIMARY SITE; CANCER STAGING; COMBINATION CHEMOTHERAPY; DRUG WITHDRAWAL; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NEUTROPHIL COUNT; PANCREAS CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING; SOLID TUMOR; ADVANCED CANCER; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; CANCER CHEMOTHERAPY; CUTANEOUS T CELL LYMPHOMA; GEMCITABINE INDUCED NEUTROPENIA; GLIOMA; OVARY CANCER; PATIENT HISTORY OF CHEMOTHERAPY;

AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILIARY TRACT NEOPLASMS; BREAST NEOPLASMS; DEOXYCYTIDINE; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUTROPENIA; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; SMOKING;

EID: 84888211480     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000355107     Document Type: Article

References (18)

1. Conney AH: Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res 1982; 42: 4875-4917.
2. Hukkanen J, Jacob P III, Peng M, Dempsey D, Benowitz NL: Effects of nicotine on cytochrome P450 2A6 and 2E1 activities. Br J Clin Pharmacol 2010; 69: 152-159.
3. Hirota T, Takane H, Higuchi S, Ieiri I: Epigenetic regulation of genes encoding drug-metabolizing enzymes and transporters; DNA methylation and other mechanisms. Curr Drug Metab 2008; 9: 34-38.
4. Kroon LA: Drug interactions with smoking. Am J Health Syst Pharm 2007; 64: 1917-1921.
5. Zevin S, Benowitz NL: Drug interactions with tobacco smoking. An update. Clin Pharmacokinet 1999; 36: 425-438.
6. Hamilton M, Wolf JL, Rusk J, Beard SE, Clark GM, Witt K, et al: Effects of smoking on the pharmacokinetics of erlotinib. Clin Cancer Res 2006; 12: 2166-2171.
7. Hughes AN, O'Brien ME, Petty WJ, Chick JB, Rankin E, Woll PJ, et al: Overcoming CYP1A1/1A2 mediated induction of metabolism by escalating erlotinib dose in current smokers. J Clin Oncol 2009; 27: 1220-1226.
8. van der Bol JM, Mathijssen RH, Loos WJ, Friberg LE, van Schaik RH, de Jonge MJ, et al: Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropenia. J Clin Oncol 2007; 25: 2719-2726.
9. de Graan AJ, Loos WJ, Friberg LE, Baker SD, van der Bol JM, van Doorn L, et al: Influence of smoking on the pharmacokinetics and toxicity profiles of taxane therapy. Clin Cancer Res 2012; 18: 4425-4432.
10. Kanai M, Morita S, Matsumoto S, Nishimura T, Hatano E, Yazumi S, et al: A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia. Ann Oncol 2009; 20: 1397-1401.
11. Launay JM, Del Pino M, Chironi G, Callebert J, Peoc'h K, Megnien JL, et al: Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation. PLoS One 2009; 4:e7959.
12. Suter M, Abramovici A, Showalter L, Hu M, Shope CD, Varner M, et al: In utero tobacco exposure epigenetically modifies placental CYP1A1 expression. Metabolism 2010; 59: 1481-1490.
13. Lu JF, Eppler SM, Wolf J, Hamilton M, Rakhit A, Bruno R, et al: Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety relationship in patients with non-small cell lung cancer. Clin Pharmacol Ther 2006; 80: 136-145.
14. VonHoff D: Activity of gemcitabine in a human tumor cloning assay as a basis for clinical trials with gemcitabine. San Antonio Drug Development Team. Invest New Drugs 1996; 14: 265-270.
15. Levitt ML, Kassem B, Gooding WE, Miketic LM, Landreneau RJ, Ferson PF, et al: Phase I study of gemcitabine given weekly as a short infusion for non-small cell lung cancer: results and possible immune system-related mechanisms. Lung Cancer 2004; 43: 335-344.
16. Spira A, Beane J, Shah V, Liu G, Schembri F, Yang X, et al: Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci USA 2004; 101: 10143-10148.
17. van Eeden SF, Hogg JC: The response of human bone marrow to chronic cigarette smoking. Eur Respir J 2000; 15: 915-921.
18. Meguid RA, Hooker CM, Harris J, Xu L, Westra WH, Sherwood JT, et al: Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers. Chest 2010; 138: 500-509.